{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:55Z","timestamp":1761864355302},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In July 1984, Taiwan officially began a nationwide hepatitis B virus (HBV) vaccination program where only infants born to HBsAg-positive mothers were vaccinated free of charge until June 1986. However, from July 1986, all infants were vaccinated against HBV. The impact of the July 1986 HBV vaccination program on first-time blood donors has not been exhaustively studied. We, therefore, determined the risk of HBV among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Initially, we recruited 857,310 first-time blood donors whose data were collected between 2013 and 2018 from 5 blood donation centers in Taiwan. However, we excluded donors with incomplete and outlying data (<jats:italic>n<\/jats:italic>\u2009=\u200912,213) and those born between July 1984 and June 1986 (<jats:italic>n<\/jats:italic>\u2009=\u200921,054). The final study participants comprised 9118 HBV positive and 814,925 HBV negative individuals. We divided the participants into two birth cohorts (born before and after July 1986) and assumed that those born before July 1986 were not vaccinated at birth while those born after July 1986 were vaccinated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of HBV among those born before and after July 1986 was 4.53 and 0.25%, respectively. Individuals born after July 1986 had a lower risk of HBV than those born before July 1986. The adjusted odds ratio (OR), 95% confidence interval (CI) was 0.16, 0.13\u20130.19. Men had a higher risk of HBV than women (OR\u2009=\u20091.40, 95% CI\u2009=\u20091.34\u20131.47). The interaction between sex and birth date was significant (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.0067). Stratification of participants by birth date revealed a higher risk of HBV in men compared to women in both birth cohorts. The OR, 95% CI was 1.47, 1.40\u20131.55 for those born before July 1986 but declined to 1.15, 1.02\u20131.29 for those born after July 1986.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The risk of HBV was lower among those born after than those born before the July 1986 vaccination program. In both cohorts, the risk was high in men relative to women. The seemingly protective effect among those born after July 1986 was higher in women than men.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11846-x","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:55:43Z","timestamp":1633899343000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of HBV infection among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan"],"prefix":"10.1186","volume":"21","author":[{"given":"Hsuan-Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Lung","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Chiou","family":"Jau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disline Manli","family":"Tantoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswald Ndi","family":"Nfor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hsiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Liang","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Po","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"8","key":"11846_CR1","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.22045","volume":"119","author":"SN Lu","year":"2006","unstructured":"Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer. 2006;119(8):1946\u201352. https:\/\/doi.org\/10.1002\/ijc.22045.","journal-title":"Int J Cancer"},{"issue":"10003","key":"11846_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X.","journal-title":"Lancet"},{"issue":"1","key":"11846_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jhep.2005.06.016","volume":"44","author":"CJ Liu","year":"2006","unstructured":"Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol. 2006;44(1):39\u201346. https:\/\/doi.org\/10.1016\/j.jhep.2005.06.016.","journal-title":"J Hepatol"},{"issue":"1","key":"11846_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","volume":"204","author":"WH Gerlich","year":"2015","unstructured":"Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015;204(1):39\u201355. https:\/\/doi.org\/10.1007\/s00430-014-0373-y.","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"11846_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","volume":"57","author":"YH Ni","year":"2012","unstructured":"Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol. 2012;57(4):730\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2012.05.021.","journal-title":"J Hepatol"},{"issue":"12","key":"11846_CR6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116.","journal-title":"Vaccine"},{"issue":"9","key":"11846_CR7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/jvh.12901","volume":"25","author":"X Tang","year":"2018","unstructured":"Tang X, Allain JP, Wang H, Rong X, Chen J, Huang K, et al. Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide. J Viral Hepat. 2018;25(9):1008\u201316. https:\/\/doi.org\/10.1111\/jvh.12901.","journal-title":"J Viral Hepat"},{"issue":"4","key":"11846_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF02779126","volume":"19","author":"JL Sung","year":"1984","unstructured":"Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn. 1984;19(4):363\u20136. https:\/\/doi.org\/10.1007\/BF02779126.","journal-title":"Gastroenterol Jpn"},{"issue":"15","key":"11846_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM197504102921503","volume":"292","author":"CE Stevens","year":"1975","unstructured":"Stevens CE, Beasley RP, Tsui J, Lee W-C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292(15):771\u20134. https:\/\/doi.org\/10.1056\/NEJM197504102921503.","journal-title":"N Engl J Med"},{"issue":"6","key":"11846_CR10","first-page":"423","volume":"25","author":"D Chen","year":"1978","unstructured":"Chen D, Sung J. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta hepato-gastroenterologica. 1978;25(6):423\u201330.","journal-title":"Acta hepato-gastroenterologica"},{"issue":"19","key":"11846_CR11","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","volume":"257","author":"D-S Chen","year":"1987","unstructured":"Chen D-S, Hsu NH-M, Sung J-L, Hsu T-C, Hsu S-T, Kuo Y-T, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen\u2014carrier mothers. Jama. 1987;257(19):2597\u2013603. https:\/\/doi.org\/10.1001\/jama.1987.03390190075023.","journal-title":"Jama"},{"issue":"2","key":"11846_CR12","first-page":"56","volume":"4","author":"Y-T Tsai","year":"1987","unstructured":"Tsai Y-T, Lo K-J, Lee S-D, Wang J-Y, Wu J-C, Chang CY, et al. A comparison of immunogenicity of reduced doses of hepatitis B vaccine in infants born to noncarrier mothers in Taiwan. \u4e2d\u83ef\u6c11\u570b\u6d88\u5316\u7cfb\u91ab\u5b78\u6703\u96dc\u8a8c. 1987;4(2):56\u201362.","journal-title":"\u4e2d\u83ef\u6c11\u570b\u6d88\u5316\u7cfb\u91ab\u5b78\u6703\u96dc\u8a8c"},{"issue":"1","key":"11846_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2893.2007.00890.x","volume":"15","author":"FH Su","year":"2008","unstructured":"Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan\u2019s national hepatitis B vaccination programme. J Viral Hepat. 2008;15(1):14\u20139. https:\/\/doi.org\/10.1111\/j.1365-2893.2007.00890.x.","journal-title":"J Viral Hepat"},{"key":"11846_CR14","doi-asserted-by":"publisher","first-page":"e4297","DOI":"10.7717\/peerj.4297","volume":"6","author":"YC Hu","year":"2018","unstructured":"Hu YC, Yeh CC, Chen RY, Su CT, Wang WC, Bai CH, et al. Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program. PeerJ. 2018;6:e4297. https:\/\/doi.org\/10.7717\/peerj.4297.","journal-title":"PeerJ"},{"issue":"1","key":"11846_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27251","volume":"6","author":"S Yang","year":"2016","unstructured":"Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6(1):1\u201312. https:\/\/doi.org\/10.1038\/srep27251.","journal-title":"Sci Rep"},{"issue":"12","key":"11846_CR16","first-page":"57","volume":"27","author":"MS Anwar","year":"2011","unstructured":"Anwar MS, Siddiqi GM, Haq S, Khokhar G, Jaffery G. Association of blood group types to hepatitis B and hepatitis C virus infection. Biomedica. 2011;27(12):57\u201361.","journal-title":"Biomedica"},{"issue":"9","key":"11846_CR17","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.7860\/JCDR\/2013\/6002.3360","volume":"7","author":"S Tyagi","year":"2013","unstructured":"Tyagi S, Tyagi A. Possible correlation of transfusion transmitted diseases with Rh type and ABO blood group system. J Clin Diagn Res. 2013;7(9):1930\u20131. https:\/\/doi.org\/10.7860\/JCDR\/2013\/6002.3360.","journal-title":"J Clin Diagn Res"},{"key":"11846_CR18","volume-title":"Churchill","author":"GL Mandell","year":"2000","unstructured":"Mandell GL. Douglas. Principles and practice of infectious disease. In: Churchill; 2000."},{"key":"11846_CR19","first-page":"177","volume-title":"Seminars in hematology: 2000","author":"M Rios","year":"2000","unstructured":"Rios M, Bianca C. The role of blood group antigens in infectious diseases. In: Seminars in hematology: 2000: Elsevier; 2000. p. 177\u201385."},{"issue":"8","key":"11846_CR20","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/ijc.28196","volume":"133","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Zhou Q, Lin Q, Chen R, Gong Y, Liu Y, et al. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism. Int J Cancer. 2013;133(8):1867\u201375. https:\/\/doi.org\/10.1002\/ijc.28196.","journal-title":"Int J Cancer"},{"issue":"7","key":"11846_CR21","doi-asserted-by":"publisher","first-page":"e1000118","DOI":"10.1371\/journal.pgen.1000118","volume":"4","author":"G Par\u00e9","year":"2008","unstructured":"Par\u00e9 G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4(7):e1000118. https:\/\/doi.org\/10.1371\/journal.pgen.1000118.","journal-title":"PLoS Genet"},{"issue":"7","key":"11846_CR22","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.18203\/2320-6012.ijrms20150249","volume":"3","author":"KV SB","year":"2015","unstructured":"SB KV, Bandi S, Kondareddy S, Madithadu A. Association of ABO and Rh blood groups to HBV, HCV infections among blood donors in a blood bank of tertiary care teaching hospital in southern India: a retrospective study. Int J Res Med Sci. 2015;3(7):1672\u20136. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20150249.","journal-title":"Int J Res Med Sci"},{"issue":"4","key":"11846_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jvh.12829","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Distribution of ABO\/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study. J Viral Hepat. 2018;25(4):401\u201311. https:\/\/doi.org\/10.1111\/jvh.12829.","journal-title":"J Viral Hepat"},{"issue":"12","key":"11846_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1046\/j.1440-1746.2000.0150121356.x","volume":"15","author":"I Merican","year":"2000","unstructured":"Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15(12):1356\u201361. https:\/\/doi.org\/10.1046\/j.1440-1746.2000.0150121356.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"11846_CR25","unstructured":"Ministry of the Interior TROCThOEtSoaAS: accessed on 10 Apr 2018."},{"issue":"1","key":"11846_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/voxs.12368","volume":"13","author":"C Seed","year":"2018","unstructured":"Seed C. Value of retaining HB sAg donor screening where HBV NAT and anti-HB c donor screening apply. ISBT Science Series. 2018;13(1):70\u20135. https:\/\/doi.org\/10.1111\/voxs.12368.","journal-title":"ISBT Science Series"},{"issue":"3pt2","key":"11846_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/trf.13946","volume":"57","author":"S Blanco","year":"2017","unstructured":"Blanco S, Balangero MC, Valle MC, Montini OL, Carrizo LH, Gallego SV. Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections. Transfusion. 2017;57(3pt2):816\u201322.","journal-title":"Transfusion"},{"key":"11846_CR28","unstructured":"Foundation ARoTBS: 2019."},{"issue":"10","key":"11846_CR29","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1111\/trf.14307","volume":"57","author":"M Goldman","year":"2017","unstructured":"Goldman M, Steele WR, Di Angelantonio E, van den Hurk K, Vassallo RR, Germain M, et al. Biomedical excellence for safer transfusion collaborative I: comparison of donor and general population demographics over time: a BEST collaborative group study. Transfusion. 2017;57(10):2469\u201376. https:\/\/doi.org\/10.1111\/trf.14307.","journal-title":"Transfusion"},{"issue":"2","key":"11846_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hep.24500","volume":"54","author":"DS Chen","year":"2011","unstructured":"Chen DS. Fighting against viral hepatitis: lessons from Taiwan. Hepatology. 2011;54(2):381\u201392. https:\/\/doi.org\/10.1002\/hep.24500.","journal-title":"Hepatology"},{"key":"11846_CR31","unstructured":"Control TCfD: access on 30 Jul 2016."},{"issue":"3","key":"11846_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.gastro.2016.05.048","volume":"151","author":"MH Chang","year":"2016","unstructured":"Chang MH, You SL, Chen CJ, Liu CJ, Lai MW, Wu TC, et al. Long-term effects of hepatitis B immunization of infants in preventing liver Cancer. Gastroenterology. 2016;151(3):472\u201380 e471. https:\/\/doi.org\/10.1053\/j.gastro.2016.05.048.","journal-title":"Gastroenterology"},{"issue":"47","key":"11846_CR33","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1016\/j.vaccine.2007.09.013","volume":"25","author":"FH Su","year":"2007","unstructured":"Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine. 2007;25(47):8085\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.013.","journal-title":"Vaccine"},{"issue":"2","key":"11846_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/hep.26498","volume":"58","author":"AK Kim","year":"2013","unstructured":"Kim AK, Dziura J, Strazzabosco M. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of Columbus or another illusion? Hepatology. 2013;58(2):819\u201321. https:\/\/doi.org\/10.1002\/hep.26498.","journal-title":"Hepatology"},{"issue":"23","key":"11846_CR35","doi-asserted-by":"publisher","first-page":"12964","DOI":"10.1128\/JVI.78.23.12964-12974.2004","volume":"78","author":"N Ray","year":"2004","unstructured":"Ray N, Bisher ME, Enquist LW. Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol. 2004;78(23):12964\u201374. https:\/\/doi.org\/10.1128\/JVI.78.23.12964-12974.2004.","journal-title":"J Virol"},{"issue":"2","key":"11846_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/jmv.20771","volume":"79","author":"FH Su","year":"2007","unstructured":"Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. Seroprevalence of hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol. 2007;79(2):138\u201343. https:\/\/doi.org\/10.1002\/jmv.20771.","journal-title":"J Med Virol"},{"issue":"2","key":"11846_CR37","first-page":"155","volume":"32","author":"P-K Tsay","year":"2009","unstructured":"Tsay P-K, Tai D-I, Chen Y-M, Yu C-P, Wan S-Y, Shen Y-J, et al. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J. 2009;32(2):155\u201364.","journal-title":"Chang Gung Med J"},{"issue":"1","key":"11846_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"C-J Chen","year":"2006","unstructured":"Chen C-J, Yang H-I, Su J, Jen C-L, You S-L, Lu S-N, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65\u201373. https:\/\/doi.org\/10.1001\/jama.295.1.65.","journal-title":"JAMA"},{"key":"11846_CR39","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","volume":"9","author":"A Ruggieri","year":"2018","unstructured":"Ruggieri A, Gagliardi MC, Anticoli S. Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Front Immunol. 2018;9:2302. https:\/\/doi.org\/10.3389\/fimmu.2018.02302.","journal-title":"Front Immunol"},{"issue":"1","key":"11846_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.61","volume":"1","author":"A Fischer","year":"2015","unstructured":"Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM. Severe combined immunodeficiencies and related disorders. Nat Rev Dis Primers. 2015;1(1):1\u201318. https:\/\/doi.org\/10.1038\/nrdp.2015.61.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"11846_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/acel.12326","volume":"14","author":"C Giefing-Kroll","year":"2015","unstructured":"Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309\u201321. https:\/\/doi.org\/10.1111\/acel.12326.","journal-title":"Aging Cell"},{"issue":"49","key":"11846_CR42","doi-asserted-by":"publisher","first-page":"12477","DOI":"10.1073\/pnas.1805268115","volume":"115","author":"AL Fink","year":"2018","unstructured":"Fink AL, Engle K, Ursin RL, Tang WY, Klein SL. Biological sex affects vaccine efficacy and protection against influenza in mice. Proc Natl Acad Sci U S A. 2018;115(49):12477\u201382. https:\/\/doi.org\/10.1073\/pnas.1805268115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"11846_CR43","doi-asserted-by":"publisher","first-page":"e12776","DOI":"10.1111\/sji.12776","volume":"90","author":"L Sarmiento","year":"2019","unstructured":"Sarmiento L, Svensson J, Barchetta I, Giwercman A, Cilio CM. Copy number of the X-linked genes TLR7 and CD40L influences innate and adaptive immune responses. Scand J Immunol. 2019;90(2):e12776. https:\/\/doi.org\/10.1111\/sji.12776.","journal-title":"Scand J Immunol"},{"issue":"10","key":"11846_CR44","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/jvh.12912","volume":"25","author":"ON Nfor","year":"2018","unstructured":"Nfor ON, Wu MF, Debnath T, Lee CT, Lee W, Liu WH, et al. Hepatitis B virus infection in Taiwan: the role of NTCP rs2296651 variant in relation to sex. J Viral Hepat. 2018;25(10):1116\u201320. https:\/\/doi.org\/10.1111\/jvh.12912.","journal-title":"J Viral Hepat"},{"issue":"1","key":"11846_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-Zugich","year":"2018","unstructured":"Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10\u20139. https:\/\/doi.org\/10.1038\/s41590-017-0006-x.","journal-title":"Nat Immunol"},{"key":"11846_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000504440","volume-title":"Vaccines for Older Adults: Current Practices and Future Opportunities. Volume 43, edn","author":"D Frasca","year":"2020","unstructured":"Frasca D, Blomberg BB. The impact of obesity and metabolic syndrome on vaccination success. In: Vaccines for Older Adults: Current Practices and Future Opportunities. Volume 43, edn: Karger Publishers; 2020. p. 86\u201397."},{"issue":"5","key":"11846_CR47","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/21645515.2016.1274475","volume":"13","author":"F Liu","year":"2017","unstructured":"Liu F, Guo Z, Dong C. Influences of obesity on the immunogenicity of hepatitis B vaccine. Hum Vaccin Immunother. 2017;13(5):1014\u20137. https:\/\/doi.org\/10.1080\/21645515.2016.1274475.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"11846_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1128\/CMR.00109-14","volume":"28","author":"L Cooling","year":"2015","unstructured":"Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28(3):801\u201370. https:\/\/doi.org\/10.1128\/CMR.00109-14.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11846_CR49","doi-asserted-by":"publisher","first-page":"e034114","DOI":"10.1136\/bmjopen-2019-034114","volume":"10","author":"W Jing","year":"2020","unstructured":"Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open. 2020;10(1):e034114. https:\/\/doi.org\/10.1136\/bmjopen-2019-034114.","journal-title":"BMJ Open"},{"issue":"7","key":"11846_CR50","first-page":"981","volume":"43","author":"F Mohammadali","year":"2014","unstructured":"Mohammadali F, Pourfathollah A. Association of ABO and Rh blood groups to blood-borne infections among blood donors in Tehran-Iran. Iran J Public Health. 2014;43(7):981\u20139.","journal-title":"Iran J Public Health"},{"issue":"3","key":"11846_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/15321819.2016.1260585","volume":"38","author":"B Olusola","year":"2017","unstructured":"Olusola B, Gometi E, Ogunsemowo O, Olaleye D, Odaibo G. High rate of hepatitis B virus infection among hairdressers in Ibadan, Nigeria. J Immunoassay Immunochem. 2017;38(3):322\u201332. https:\/\/doi.org\/10.1080\/15321819.2016.1260585.","journal-title":"J Immunoassay Immunochem"},{"issue":"1","key":"11846_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12879-018-3376-2","volume":"18","author":"ER Shao","year":"2018","unstructured":"Shao ER, Mboya IB, Gunda DW, Ruhangisa FG, Temu EM, Nkwama ML, et al. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infect Dis. 2018;18(1):474. https:\/\/doi.org\/10.1186\/s12879-018-3376-2.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11846_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kjms.2011.10.027","volume":"28","author":"S Wait","year":"2012","unstructured":"Wait S, Chen D-S. Towards the eradication of hepatitis B in Taiwan. Kaohsiung J Med Sci. 2012;28(1):1\u20139. https:\/\/doi.org\/10.1016\/j.kjms.2011.10.027.","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"11846_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ypmed.2009.02.002","volume":"48","author":"CF Huang","year":"2009","unstructured":"Huang CF, Dai CY, Chuang WL, Ho CK, Wu TC, Hou NJ, et al. HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study. Prev Med. 2009;48(4):397\u2013400. https:\/\/doi.org\/10.1016\/j.ypmed.2009.02.002.","journal-title":"Prev Med"},{"key":"11846_CR55","unstructured":"Ministry of the Interior TROC: access on 09 Mar 2019."},{"issue":"2","key":"11846_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5812\/hepatmon.4909","volume":"12","author":"MR Ghadir","year":"2012","unstructured":"Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012;12(2):112\u20137. https:\/\/doi.org\/10.5812\/hepatmon.4909.","journal-title":"Hepat Mon"},{"issue":"09","key":"11846_CR57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/fvl-2018-0051","volume":"13","author":"E-Q Chen","year":"2018","unstructured":"Chen E-Q, Ma Y-J, Wang J, He F, Zhou T-Y, Ji Y-L, et al. Prevalence of hepatitis B virus infection in western China: epidemiological survey results of general adult population. Futur Virol. 2018;13(09):629\u201336. https:\/\/doi.org\/10.2217\/fvl-2018-0051.","journal-title":"Futur Virol"},{"issue":"9","key":"11846_CR58","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cgh.2016.04.030","volume":"14","author":"YH Ni","year":"2016","unstructured":"Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, et al. Continuing decrease in hepatitis B virus infection 30 years after initiation of infant vaccination program in Taiwan. Clin Gastroenterol Hepatol. 2016;14(9):1324\u201330. https:\/\/doi.org\/10.1016\/j.cgh.2016.04.030.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"11846_CR59","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7326\/0003-4819-135-9-200111060-00009","volume":"135","author":"Y-H Ni","year":"2001","unstructured":"Ni Y-H, Chang M-H, Huang L-M, Chen H-L, Hsu H-Y, Chiu T-Y, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135(9):796\u2013800. https:\/\/doi.org\/10.7326\/0003-4819-135-9-200111060-00009.","journal-title":"Ann Intern Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11846-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:58:46Z","timestamp":1633899526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11846-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11846"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11846-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out following relevant guidelines and regulations. Informed consent was obtained from all participants. Ethical approval was obtained from the Ethical Review Board of the Taiwan Blood Services Foundation (PM-108-TC-197).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1831"}}